US valuation of the EQ-5D health states - Development and testing of the D1 valuation model

被引:1076
作者
Shaw, JW
Johnson, JA
Coons, SJ
机构
[1] Univ Arizona, Coll Pharm, Ctr Hlth Outcomes & PharamcoEcon Res, Tucson, AZ 85721 USA
[2] Univ Alberta, Edmonton, AB, Canada
[3] Inst Hlth Econ, Edmonton, AB, Canada
[4] NCI, Tobacco Control Res Branch, Behav Res Program, Div Canc Control & Populat Sci, Bethesda, MD 20892 USA
关键词
EQ-5D; health status; preference weights; time trade-off (TTO);
D O I
10.1097/00005650-200503000-00003
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Purpose: The EQ-5D is a brief, multiattribute, preference-based health status measure. This article describes the development of a statistical model for generating US population-based EQ-5D preference weights. Methods: A multistage probability sample was selected from the US adult civilian noninstitutional population. Respondents valued 13 of 243 EQ-5D health states using the time trade-off (TTO) method. Data for 12 states were used in econometric modeling. The TTO valuations were linearly transformed to lie on the interval [-1, 1]. Methods were investigated to account for interaction effects caused by having problems in multiple EQ-5D dimensions. Several alternative model specifications (eg, pooled least squares, random effects) also were considered. A modified split-sample approach was used to evaluate the predictive accuracy of the models. All statistical analyses took into account the clustering and disproportionate selection probabilities inherent in our sampling design. Results: Our D1 model for the EQ-5D included ordinal terms to capture the effect of departures from perfect health as well as interaction effects. A random effects specification of the D1 model yielded a good fit for the observed TTO data, with an overall R-2 of 0.38, a mean absolute error of 0.025, and 7 prediction errors exceeding 0.05 in absolute magnitude. Conclusions: The D1 model best predicts the values for observed health states. The resulting preference weight estimates represent a significant enhancement of the EQ-5D's utility for health status assessment and economic analysis in the US.
引用
收藏
页码:203 / 220
页数:18
相关论文
共 48 条
[1]  
[Anonymous], 1996, Quality of Life and Pharmacoeconomics in Clinical Trials
[2]   A comparison of United Kingdom and Spanish general population time trade-off values for EQ-5D health states [J].
Badia, X ;
Roset, M ;
Herdman, M ;
Kind, P .
MEDICAL DECISION MAKING, 2001, 21 (01) :7-16
[3]  
Belsley DA, 1980, Regression Diagnostics: Identifying Influential Data and Sources of Collinearity
[5]   EuroQol: The current state of play [J].
Brooks, R .
HEALTH POLICY, 1996, 37 (01) :53-72
[6]  
CLAES C, 1999, P 15 PLEN M EUROQOL, P13
[7]  
COHEN SB, 2003, MED CARE S, V41, pII15
[8]  
COONS SJ, 2005, PRINCIPLES PHARMACOE, P117
[9]  
Cox BG, 1980, P SURV RES METH SECT, P721
[10]   Modeling valuations for EuroQol health states [J].
Dolan, P .
MEDICAL CARE, 1997, 35 (11) :1095-1108